How do you approach post-operative SRS for melanoma metastases in the setting of immunotherapy?

Do you uniformly recommend adjuvant treatment or reserve SRS for a subtotal resection and/or recurrent disease?

Answer from: Radiation Oncologist at Academic Institution

I always offer postop SRS or HSRT as after surgery, the blood supply of the area will be compromised affecting drug delivery.